Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

Booster vaccinations against cancer are critical in prophylactic but detrimental in therapeutic settings.

Ricupito A, Grioni M, Calcinotto A, Hess Michelini R, Longhi R, Mondino A, Bellone M.

Cancer Res. 2013 Jun 15;73(12):3545-54. doi: 10.1158/0008-5472.CAN-12-2449. Epub 2013 Mar 28.

PMID:
23539449
[PubMed - indexed for MEDLINE]
Free Article
2.

[Ad hTRP2 - mediated immunity against melanoma is enhanced by dendritic cells pulsed with peptide].

Tan XH, Liu C, Wan YH.

Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):658-61. Chinese.

PMID:
17274369
[PubMed - indexed for MEDLINE]
3.

Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+) T cell/regulatory T cells in tumour.

Song S, Zhang K, You H, Wang J, Wang Z, Yan C, Liu F.

Clin Exp Immunol. 2010 Oct;162(1):75-83. doi: 10.1111/j.1365-2249.2010.04226.x.

PMID:
20735440
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.

Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.

Int J Oncol. 2006 Apr;28(4):947-53.

PMID:
16525645
[PubMed - indexed for MEDLINE]
5.

Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.

Xia D, Zheng S, Zhang W, He L, Wang Q, Pan J, Zhang L, Wang J, Cao X.

J Mol Med (Berl). 2003 Sep;81(9):585-96. Epub 2003 Aug 21.

PMID:
12937899
[PubMed - indexed for MEDLINE]
6.

Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.

Goldszmid RS, Idoyaga J, Bravo AI, Steinman R, Mordoh J, Wainstok R.

J Immunol. 2003 Dec 1;171(11):5940-7.

PMID:
14634105
[PubMed - indexed for MEDLINE]
Free Article
7.

Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice.

Ribas A, Butterfield LH, Hu B, Dissette VB, Meng WS, Koh A, Andrews KJ, Lee M, Amar SN, Glaspy JA, McBride WH, Economou JS.

Cancer Res. 2000 Apr 15;60(8):2218-24.

PMID:
10786687
[PubMed - indexed for MEDLINE]
Free Article
8.

DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells.

Kim D, Hung CF, Wu TC, Park YM.

Vaccine. 2010 Oct 21;28(45):7297-305. doi: 10.1016/j.vaccine.2010.08.079. Epub 2010 Sep 17.

PMID:
20817010
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signaling.

Xie Y, Wang L, Freywald A, Qureshi M, Chen Y, Xiang J.

Cell Mol Immunol. 2013 Jan;10(1):72-7. doi: 10.1038/cmi.2012.37. Epub 2012 Oct 8.

PMID:
23042534
[PubMed - indexed for MEDLINE]
10.

Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells.

Tanaka Y, Koido S, Ohana M, Liu C, Gong J.

J Immunol. 2005 Feb 1;174(3):1274-80.

PMID:
15661883
[PubMed - indexed for MEDLINE]
Free Article
11.

Intratumoral injection of interferon-gamma gene-modified dendritic cells elicits potent antitumor effects: effective induction of tumor-specific CD8+ CTL response.

Pan J, Zhang M, Wang J, Wang Q, Xia D, Sun W, Zhang L, Yu H, Cao X.

J Cancer Res Clin Oncol. 2005 Jul;131(7):468-78. Epub 2005 Feb 12.

PMID:
15711825
[PubMed - indexed for MEDLINE]
12.

Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction.

Kim KD, Choi SC, Kim A, Choe YK, Choe IS, Lim JS.

Int Immunopharmacol. 2001 Nov;1(12):2117-29.

PMID:
11710541
[PubMed - indexed for MEDLINE]
13.

Tumor vaccine composed of C-class CpG oligodeoxynucleotides and irradiated tumor cells induces long-term antitumor immunity.

Cerkovnik P, Novakovic BJ, Stegel V, Novakovic S.

BMC Immunol. 2010 Sep 13;11:45. doi: 10.1186/1471-2172-11-45.

PMID:
20836870
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.

Winter H, Hu HM, McClain K, Urba WJ, Fox BA.

J Immunol. 2001 Jun 15;166(12):7370-80.

PMID:
11390488
[PubMed - indexed for MEDLINE]
Free Article
15.

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.

Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F.

Cancer Immunol Immunother. 2004 Nov;53(11):963-77. Epub 2004 May 14.

PMID:
15146294
[PubMed - indexed for MEDLINE]
16.

Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants.

Ali OA, Verbeke C, Johnson C, Sands RW, Lewin SA, White D, Doherty E, Dranoff G, Mooney DJ.

Cancer Res. 2014 Mar 15;74(6):1670-81. doi: 10.1158/0008-5472.CAN-13-0777. Epub 2014 Jan 30.

PMID:
24480625
[PubMed - indexed for MEDLINE]
17.

Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.

Wang B, Zaidi N, He LZ, Zhang L, Kuroiwa JM, Keler T, Steinman RM.

Breast Cancer Res. 2012 Mar 7;14(2):R39.

PMID:
22397502
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.

André F, Chaput N, Schartz NE, Flament C, Aubert N, Bernard J, Lemonnier F, Raposo G, Escudier B, Hsu DH, Tursz T, Amigorena S, Angevin E, Zitvogel L.

J Immunol. 2004 Feb 15;172(4):2126-36.

PMID:
14764678
[PubMed - indexed for MEDLINE]
Free Article
19.

Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.

Kim A, Noh YW, Kim KD, Jang YS, Choe YK, Lim JS.

Exp Mol Med. 2004 Oct 31;36(5):428-43.

PMID:
15557815
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk